January 2024 Stock Gainers on News, Micro Caps Included
Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.
Data as of the trading session of , 21 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
Whole board, unfiltered
100
Ranked gains
+316.25%
Largest, LBPH
90.0%
Above baseline, day +5
13.1%
Median give-back, day +5
Filter and sort
100 ranked gains in January 2024
Skip the ranked rows and go to the month summaryEvery percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.
| Rank | Symbol | close to close | Session | Catalyst | Announcement | from the pre-news close |
|---|---|---|---|---|---|---|
| 1 | LBPH | +316.25% |
against the close of 2023-12-29
session reconstructed
Session detail |
Clinical Trial Results |
Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)
08:00 ET premarket |
8.4% of the move was gone five sessions later. Month end +252.24% on 2024-01-31 |
| 2 | CRBP | +249.41% |
against the close of 2024-01-25
session reconstructed
Session detail |
Other Announcement |
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024
07:30 ET premarket |
13.2% of the move was gone five sessions later. Month end +213.86% on 2024-01-31 This month ended before the fifth session after the move. |
| 3 | MIMO | +186.09% |
against the close of 2024-01-16
session reconstructed
Session detail |
Other Announcement |
Airspan Revolutionizes Utilities Market with Groundbreaking End-to-End Solution
08:41 ET premarket |
26.6% of the move was gone five sessions later. Month end +194.02% on 2024-01-31 |
| 4 | SGMT Also on the opposite board this month on both boards | +170.09% |
against the close of 2024-01-19
session reconstructed
Session detail |
Clinical Trial Results |
Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
07:00 ET premarket |
67.4% of the move was gone five sessions later. Month end +39.00% on 2024-01-31 |
| 5 | ONMD | +168.21% |
against the close of 2024-01-26
session reconstructed
Session detail |
Other Announcement |
OneMedNet Announces Participation as an Exhibitor at the 15ᵗʰ Annual SCOPE Summit
08:00 ET premarket |
18.6% of the move was gone five sessions later. Month end +270.01% on 2024-01-31 This month ended before the fifth session after the move. |
| 6 | PCSA under $25M today Also on the opposite board this month on both boards | +148.78% |
against the close of 2024-01-24
session reconstructed
Session detail |
Clinical Trial Results |
Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses
08:30 ET premarket |
90.5% of the move was gone five sessions later. Month end +15.12% on 2024-01-31 This month ended before the fifth session after the move. |
| 7 | EVAX More than one ranked move this month 2+ ranked moves | +113.43% |
against the close of 2024-01-23
session reconstructed
Session detail |
Other Announcement |
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
08:30 ET premarket |
It gave back the whole move and closed 21.24% below the pre-news price. Month end -21.24% on 2024-01-31 |
| 8 | HARP | +111.94% |
against the close of 2024-01-05
session reconstructed
Session detail |
M&A / Acquisition |
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
07:30 ET premarket |
Five sessions later the move was 0.5% bigger, at +112.51%. Month end +111.66% on 2024-01-31 |
| 9 | FAZE Also on the opposite board this month on both boards | +107.12% |
against the close of 2024-01-22
session reconstructed
Session detail |
Other Announcement |
FaZe Clan and Rollbit Announce Multi-Million Dollar Esports Sponsorship Deal
07:00 ET premarket |
79.7% of the move was gone five sessions later. Month end +19.09% on 2024-01-31 |
| 10 | AMAM | +101.54% |
against the close of 2024-01-05
session reconstructed
Session detail |
M&A / Acquisition |
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
07:30 ET premarket |
Five sessions later the move was 1.5% bigger, at +103.08%. Month end +103.96% on 2024-01-31 |
| 11 | CNXA | +101.21% |
against the close of 2024-01-30
session reconstructed
Session detail |
Uplisting / Compliance |
Connexa Announces that it has regained compliance with the Nasdaq Minimum Shareholder Equity Rule
09:00 ET premarket |
62.0% of the move was gone five sessions later. Month end +101.21% on 2024-01-31 same session This month ended before the fifth session after the move. |
| 12 | KAMN | +100.85% |
against the close of 2024-01-18
session reconstructed
Session detail |
M&A / Acquisition |
Kaman to be Acquired by Arcline for $1.8 Billion
08:00 ET premarket |
0.2% of the move was gone five sessions later. Month end +100.85% on 2024-01-31 |
| 13 | PALI Also on the opposite board this month on both boards | +84.62% |
against the close of 2024-01-26
session reconstructed
Session detail |
Clinical Trial Results |
Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn’s & Colitis Congress
08:05 ET premarket |
It gave back the whole move and closed 1.92% below the pre-news price. Month end +15.29% on 2024-01-31 This month ended before the fifth session after the move. |
| 14 | KITT under $25M today | +78.65% |
against the close of 2024-01-09
session reconstructed
Session detail |
Leadership Change |
Nauticus Robotics Secures Additional Funding, Appoints New Executive Management, Improves Operations and Cost Structures, and Engages Strategic Advisor
06:15 ET premarket |
62.5% of the move was gone five sessions later. Month end +48.98% on 2024-01-31 |
| 15 | GETR under $25M today | +76.28% |
against the close of 2024-01-23
session reconstructed
Session detail |
Earnings |
Getaround Secures $20 Million in Financing, Following Strong Q3 2023 Results
18:58 ET after hours |
52.1% of the move was gone five sessions later. Month end +36.56% on 2024-01-31 |
| 16 | SIDU Also on the opposite board this month on both boards | +67.00% |
against the close of 2024-01-02
session reconstructed
Session detail |
Other Announcement |
Sidus Space Secures NOAA Approval to Provide Imaging Services to Government and Commercial Customers
08:30 ET premarket |
Five sessions later the move was 29.3% bigger, at +86.66%. Month end -31.13% on 2024-01-31 |
| 17 | RVSN under $25M today | +64.23% |
against the close of 2024-01-19
session reconstructed
Session detail |
Other Announcement |
Rail Vision's Main Line System Successfully Secures Approval and Certifications and for EU Railway Standards
07:33 ET premarket |
Five sessions later the move was 1413.7% bigger, at +972.26%. Month end +987.59% on 2024-01-31 |
| 18 | ABVC under $25M today | +60.83% |
against the close of 2024-01-02
session reconstructed
Session detail |
Other Announcement |
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
07:24 ET premarket |
50.7% of the move was gone five sessions later. Month end +26.67% on 2024-01-31 |
| 19 | CELU under $25M today | +53.48% |
against the close of 2024-01-17
session reconstructed
Session detail |
Other Announcement |
Celularity Releases CEO Letter to Shareholders
13:40 ET intraday |
Five sessions later the move was 58.6% bigger, at +84.81%. Month end +101.81% on 2024-01-31 |
| 20 | DATS under $25M today Also on the opposite board this month on both boards | +51.79% |
against the close of 2024-01-12
session reconstructed
Session detail |
Other Announcement |
DatChat Issues Shareholder Letter and Provides Corporate Update
10:30 ET intraday |
It gave back the whole move and closed 31.74% below the pre-news price. Month end -33.17% on 2024-01-31 |
| 21 | MESA | +49.98% |
against the close of 2024-01-18
session reconstructed
Session detail |
Other Announcement |
Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program
16:20 ET after hours |
Five sessions later the move was 9.3% bigger, at +54.65%. Month end +42.38% on 2024-01-31 |
| 22 | VERA | +48.71% |
against the close of 2024-01-24
session reconstructed
Session detail |
Clinical Trial Results |
Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy
06:30 ET premarket |
Five sessions later the move was 153.1% bigger, at +123.27%. Month end +113.98% on 2024-01-31 This month ended before the fifth session after the move. |
| 23 | NUBI release reads negative | +48.66% |
against the close of 2024-01-10
session reconstructed
Session detail |
Reverse Merger / Shell Release reads negative, stock rose 48.66% |
NUBIA BRAND INTERNATIONAL CORP. PROVIDES UPDATE ON REDEMPTION REVERSAL REQUESTS IN CONNECTION WITH CLOSING ITS BUSINESS COMBINATION
14:12 ET intraday |
21.6% of the move was gone five sessions later. Month end +5.98% on 2024-01-31 |
| 24 | FFNW | +48.03% |
against the close of 2024-01-10
session reconstructed
Session detail |
M&A / Acquisition |
Global Credit Union and First Financial Northwest, Inc. Announce Agreement for Global Credit Union to Acquire First Financial Northwest Bank
09:10 ET premarket |
Five sessions later the move was 10.6% bigger, at +53.14%. Month end +52.63% on 2024-01-31 |
| 25 | ELEV under $25M today | +47.81% |
against the close of 2024-01-04
session reconstructed
Session detail |
Other Announcement |
Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
07:30 ET premarket |
Five sessions later the move was 659.4% bigger, at +363.07%. Month end +369.83% on 2024-01-31 |
| 26 | MOBX under $25M today | +47.30% |
against the close of 2024-01-03
session reconstructed
Session detail |
Contract / Partnership |
Mobix Labs Awarded M-1 Abrams Tank Contract for U.S. Army
08:05 ET premarket |
It gave back the whole move and closed 3.72% below the pre-news price. Month end -8.28% on 2024-01-31 |
| 27 | KURA release reads negative | +46.13% |
against the close of 2024-01-23
session reconstructed
Session detail |
Offering / Dilution Rose on dilution Release reads negative, stock rose 46.13% |
Kura Oncology Announces Oversubscribed $150 Million Private Placement
07:00 ET premarket |
Five sessions later the move was 8.5% bigger, at +50.07%. Month end +50.07% on 2024-01-31 |
| 28 | POWL | +45.28% |
against the close of 2024-01-30
session reconstructed
Session detail |
Earnings |
Powell Industries Announces Fiscal 2024 First Quarter Results
16:30 ET after hours |
Five sessions later the move was 36.7% bigger, at +61.91%. Month end +45.27% on 2024-01-31 same session This month ended before the fifth session after the move. |
| 29 | LVTX | +42.95% |
against the close of 2024-01-24
session reconstructed
Session detail |
Contract / Partnership |
LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®
07:00 ET premarket |
83.6% of the move was gone five sessions later. Month end +7.05% on 2024-01-31 This month ended before the fifth session after the move. |
| 30 | MNTS | +41.86% |
against the close of 2024-01-30
session reconstructed
Session detail |
Other Announcement |
Momentus Completes All Requirements of the National Security Agreement (NSA)
08:00 ET premarket |
21.3% of the move was gone five sessions later. Month end +41.86% on 2024-01-31 same session This month ended before the fifth session after the move. |
| 31 | CYN under $25M today | +41.28% |
against the close of 2024-01-22
session reconstructed
Session detail |
Other Announcement |
Cyngn Increases Commercialization of AI-Powered Autonomous Vehicle Solutions in 2023
07:05 ET premarket |
Five sessions later the move was 78.8% bigger, at +73.80%. Month end +88.97% on 2024-01-31 |
| 32 | WGS | +40.36% |
against the close of 2024-01-05
session reconstructed
Session detail |
Earnings |
GeneDx Announces Preliminary 2023 Financial Results
08:55 ET premarket |
47.7% of the move was gone five sessions later. Month end +40.00% on 2024-01-31 |
| 33 | AEVA | +38.36% |
against the close of 2024-01-02
session reconstructed
Session detail |
Contract / Partnership |
Aeva Selected by Top Global Automotive OEM to Directly Supply LiDAR for its Series Production Program
07:00 ET premarket |
Five sessions later the move was 32.1% bigger, at +50.68%. Month end +16.71% on 2024-01-31 |
| 34 | SASI | +37.93% |
against the close of 2024-01-02
session reconstructed
Session detail |
M&A / Acquisition |
Sigma Additive Solutions Completes Acquisition of Travel Technology Company NextTrip Holdings
08:30 ET premarket |
10.9% of the move was gone five sessions later. Month end +16.55% on 2024-01-31 |
| 35 | MDIA | +36.95% |
against the close of 2023-12-29
session reconstructed
Session detail |
Other Announcement |
MediaCo Holding Inc. Announces Chris Squire as Senior Vice President of Sales and Marketing for HOT 97 and WBLS
12:37 ET intraday |
13.0% of the move was gone five sessions later. Month end +29.22% on 2024-01-31 |
| 36 | EVAX More than one ranked move this month 2+ ranked moves | +36.29% |
against the close of 2024-01-22
session reconstructed
Session detail |
Other Announcement |
Evaxion Announces Completion of ADS Ratio Change
16:30 ET after hours |
Five sessions later the move was 60.2% bigger, at +58.14%. Month end +7.34% on 2024-01-31 |
| 37 | RUM More than one ranked move this month 2+ ranked moves | +36.21% |
against the close of 2024-01-19
session reconstructed
Session detail |
Contract / Partnership |
Rumble Announces Partnership With Barstool Sports
09:00 ET premarket |
Five sessions later the move was 123.1% bigger, at +80.78%. Month end +90.81% on 2024-01-31 |
| 38 | SMCI | +35.94% |
against the close of 2024-01-18
session reconstructed
Session detail |
Earnings |
Supermicro Provides Second Quarter Fiscal 2024 Business Update
16:05 ET after hours |
Five sessions later the move was 45.4% bigger, at +52.24%. Month end +70.05% on 2024-01-31 |
| 39 | AMSC Also on the opposite board this month on both boards | +35.90% |
against the close of 2024-01-24
session reconstructed
Session detail |
Earnings |
AMSC Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Business Outlook
16:05 ET after hours |
55.4% of the move was gone five sessions later. Month end +12.82% on 2024-01-31 This month ended before the fifth session after the move. |
| 40 | TRIB under $25M today | +35.66% |
against the close of 2024-01-30
session reconstructed
Session detail |
Contract / Partnership |
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India
07:02 ET premarket |
44.5% of the move was gone five sessions later. Month end +35.66% on 2024-01-31 same session This month ended before the fifth session after the move. |
| 41 | CUTR under $25M today | +34.65% |
against the close of 2024-01-08
session reconstructed
Session detail |
Earnings |
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2023
08:00 ET premarket |
68.4% of the move was gone five sessions later. Month end -19.76% on 2024-01-31 |
| 42 | EWTX | +34.57% |
against the close of 2024-01-18
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock
08:37 ET premarket |
Five sessions later the move was 103.9% bigger, at +70.49%. Month end +84.00% on 2024-01-31 |
| 43 | LDTC under $25M today | +34.03% |
against the close of 2024-01-08
session reconstructed
Session detail |
Other Announcement |
LeddarTech Supports Accelerated L2/L2+ ADAS Development by Releasing the LeddarVision Surround-View Premium Highway Assist Software Stack on an Embedded Platform
00:07 ET premarket |
Five sessions later the move was 19.7% bigger, at +40.75%. Month end +12.66% on 2024-01-31 |
| 44 | SYT Also on the opposite board this month on both boards | +33.82% |
against the close of 2024-01-11
session reconstructed
Session detail |
M&A / Acquisition |
SYLA Technologies Became the Largest Shareholder of RIBERESUTE by Acquiring 20.39% of its Shares
09:00 ET premarket |
96.5% of the move was gone five sessions later. Month end -1.68% on 2024-01-31 |
| 45 | RUM More than one ranked move this month 2+ ranked moves | +32.92% |
against the close of 2024-01-22
session reconstructed
Session detail |
Other Announcement |
Rumble Announces Public Launch of Rumble Studio
08:00 ET premarket |
25.5% of the move was gone five sessions later. Month end +40.08% on 2024-01-31 |
| 46 | AMRN | +32.87% |
against the close of 2024-01-09
session reconstructed
Session detail |
Earnings |
Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
07:00 ET premarket |
62.7% of the move was gone five sessions later. Month end +16.39% on 2024-01-31 |
| 47 | ARDX | +32.79% |
against the close of 2024-01-05
session reconstructed
Session detail |
Other Announcement |
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities
08:00 ET premarket |
Five sessions later the move was 29.7% bigger, at +42.53%. Month end +41.72% on 2024-01-31 |
| 48 | AZTR under $25M today | +32.50% |
against the close of 2024-01-12
session reconstructed
Session detail |
Other Announcement |
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US
09:00 ET premarket |
43.6% of the move was gone five sessions later. Month end 0.00% on 2024-01-31 |
| 49 | SATS | +31.52% |
against the close of 2024-01-09
session reconstructed
Session detail |
M&A / Acquisition |
ECHOSTAR CORPORATION UNLOCKS INCREMENTAL STRATEGIC, FINANCIAL AND OPERATING FLEXIBILITY FOLLOWING COMPLETION OF MERGER WITH DISH NETWORK CORPORATION
06:00 ET premarket |
Five sessions later the move was 14.3% bigger, at +36.02%. Month end +5.77% on 2024-01-31 |
| 50 | DYN | +31.28% |
against the close of 2024-01-03
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
16:25 ET after hours |
64.5% of the move was gone five sessions later. Month end +44.89% on 2024-01-31 |
| 51 | PLUG | +30.99% |
against the close of 2024-01-22
session reconstructed
Session detail |
Other Announcement |
Plug Power Starts Production of Liquid Green Hydrogen at its Georgia Plant
09:00 ET premarket |
Five sessions later the move was 1.1% bigger, at +31.34%. Month end +56.69% on 2024-01-31 |
| 52 | OTLK | +30.53% |
against the close of 2024-01-22
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010
08:00 ET premarket |
27.7% of the move was gone five sessions later. Month end +13.53% on 2024-01-31 |
| 53 | TDCX | +30.43% |
against the close of 2024-01-02
session reconstructed
Session detail |
M&A / Acquisition |
TDCX Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Remaining Outstanding Class A Ordinary Shares of the Company
06:05 ET premarket |
Five sessions later the move was 12.9% bigger, at +34.37%. Month end +29.81% on 2024-01-31 |
| 54 | SHOT | +29.61% |
against the close of 2024-01-16
session reconstructed
Session detail |
Other Announcement |
Litigation Update - Safety Shot Authorized to Serve Notice of Action Against Capybara Research and Igor Appelboom by Public Disclosure and Press Release Pursuant to Court Order
16:10 ET after hours |
28.3% of the move was gone five sessions later. Month end +74.30% on 2024-01-31 |
| 55 | VXRT | +29.41% |
against the close of 2024-01-12
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
09:25 ET premarket |
Five sessions later the move was 43.0% bigger, at +42.05%. Month end +110.68% on 2024-01-31 |
| 56 | FLXS | +29.19% |
against the close of 2024-01-11
session reconstructed
Session detail |
Earnings |
Flexsteel Industries, Inc. Reports Strong Preliminary Results for Second Quarter; Forecasts Continued Sales Growth and Robust Profit Improvement
16:10 ET after hours |
Five sessions later the move was 115.6% bigger, at +62.93%. Month end +58.32% on 2024-01-31 |
| 57 | ACCD | +29.00% |
against the close of 2024-01-08
session reconstructed
Session detail |
Earnings |
Accolade Announces Results for Fiscal Third Quarter 2024
16:03 ET after hours |
83.4% of the move was gone five sessions later. Month end -2.58% on 2024-01-31 |
| 58 | GNS More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | +28.77% |
against the close of 2024-01-23
session reconstructed
Session detail |
M&A / Acquisition |
Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow
08:30 ET premarket |
82.9% of the move was gone five sessions later. Month end +4.93% on 2024-01-31 |
| 59 | TCN | +28.27% |
against the close of 2024-01-18
session reconstructed
Session detail |
Other Announcement |
Blackstone Real Estate to Take Tricon Residential Private
08:46 ET premarket |
2.1% of the move was gone five sessions later. Month end +27.81% on 2024-01-31 |
| 60 | APPF | +28.26% |
against the close of 2024-01-25
session reconstructed
Session detail |
Earnings |
AppFolio, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
16:05 ET after hours |
Five sessions later the move was 8.4% bigger, at +30.62%. Month end +25.74% on 2024-01-31 This month ended before the fifth session after the move. |
| 61 | SANM | +28.20% |
against the close of 2024-01-29
session reconstructed
Session detail |
Earnings |
Sanmina's First Quarter Fiscal 2024 Financial Results
16:02 ET after hours |
47.0% of the move was gone five sessions later. Month end +18.15% on 2024-01-31 This month ended before the fifth session after the move. |
| 62 | CYCC under $25M today | +28.11% |
against the close of 2024-01-05
session reconstructed
Session detail |
Uplisting / Compliance |
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
09:15 ET premarket |
It gave back the whole move and closed 10.44% below the pre-news price. Month end -10.04% on 2024-01-31 |
| 63 | SLDP | +27.35% |
against the close of 2024-01-22
session reconstructed
Session detail |
Buyback / Dividend |
Solid Power Announces $50 Million Share Repurchase Authorization
08:00 ET premarket |
Five sessions later the move was 46.9% bigger, at +40.17%. Month end +38.46% on 2024-01-31 |
| 64 | SNES under $25M today More than one ranked move this month 2+ ranked moves | +26.89% |
against the close of 2024-01-22
session reconstructed
Session detail |
Other Announcement |
SenesTech to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
09:00 ET premarket |
53.1% of the move was gone five sessions later. Month end +8.26% on 2024-01-31 |
| 65 | MAIA More than one ranked move this month 2+ ranked moves | +26.89% |
against the close of 2024-01-04
session reconstructed
Session detail |
Other Announcement |
MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024
08:00 ET premarket |
It gave back the whole move and closed 7.56% below the pre-news price. Month end +26.05% on 2024-01-31 |
| 66 | GNS More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | +26.68% |
against the close of 2024-01-19
session reconstructed
Session detail |
Other Announcement |
Genius Group 2024 Financial Guidance: 110% Growth to $56m - $60m Revenue with Positive EBITDA
08:30 ET premarket |
Five sessions later the move was 66.9% bigger, at +44.52%. Month end +31.16% on 2024-01-31 |
| 67 | AXGN | +26.67% |
against the close of 2024-01-04
session reconstructed
Session detail |
Guidance Change |
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
16:45 ET after hours |
36.1% of the move was gone five sessions later. Month end +43.26% on 2024-01-31 |
| 68 | RTC under $25M today Also on the opposite board this month on both boards | +26.44% |
against the close of 2024-01-26
session reconstructed
Session detail |
Other Announcement |
BaiJiaYun's international footprint is expanding once again, as the company ventures into the Vietnamese market for exploration and exchange
09:15 ET premarket |
It gave back the whole move and closed 87.95% below the pre-news price. Month end -85.29% on 2024-01-31 This month ended before the fifth session after the move. |
| 69 | MPU under $25M today | +26.38% |
against the close of 2024-01-19
session reconstructed
Session detail |
Other Announcement |
Mega Matrix Announces FlexTV’S Surge Into Top Ten Free Iphone Entertainment Apps (U.S.) as of JAN. 21, 2024
08:30 ET premarket |
93.0% of the move was gone five sessions later. Month end -3.07% on 2024-01-31 |
| 70 | SRTS | +26.32% |
against the close of 2024-01-22
session reconstructed
Session detail |
Other Announcement |
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
08:00 ET premarket |
7.1% of the move was gone five sessions later. Month end +22.18% on 2024-01-31 |
| 71 | CATX | +26.12% |
against the close of 2024-01-17
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement
07:00 ET premarket |
31.6% of the move was gone five sessions later. Month end +85.71% on 2024-01-31 |
| 72 | SNES under $25M today More than one ranked move this month 2+ ranked moves | +25.98% |
against the close of 2023-12-29
session reconstructed
Session detail |
Contract / Partnership |
SenesTech Signs Expanded Distribution Agreement for Evolve™ Soft Bait Sales into the United Arab Emirates (UAE)
09:00 ET premarket |
It gave back the whole move and closed 4.72% below the pre-news price. Month end -38.19% on 2024-01-31 |
| 73 | TGAN | +25.86% |
against the close of 2024-01-10
session reconstructed
Session detail |
M&A / Acquisition |
Renesas to Acquire Transphorm to Expand its Power Portfolio with GaN Technology
01:00 ET premarket |
Five sessions later the move was 6.1% bigger, at +27.44%. Month end +27.70% on 2024-01-31 |
| 74 | BCRX | +25.62% |
against the close of 2024-01-05
session reconstructed
Session detail |
Other Announcement |
BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability
16:01 ET after hours |
100.0% of the move was gone five sessions later. Month end -12.97% on 2024-01-31 |
| 75 | ACRS Also on the opposite board this month on both boards | +25.54% |
against the close of 2024-01-12
session reconstructed
Session detail |
Leadership Change |
Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review
07:00 ET premarket |
Five sessions later the move was 50.9% bigger, at +38.53%. Month end +25.54% on 2024-01-31 |
| 76 | PRPL under $25M today | +25.50% |
against the close of 2024-01-23
session reconstructed
Session detail |
Other Announcement |
Purple Innovation Strengthens Balance Sheet, Creating Greater Financial Flexibility to Execute Growth Strategy
16:05 ET after hours |
4.8% of the move was gone five sessions later. Month end +24.28% on 2024-01-31 |
| 77 | ATRA | +25.28% |
against the close of 2024-01-05
session reconstructed
Session detail |
Offering / Dilution Rose on dilution |
Atara Biotherapeutics Announces $15 Million Registered Direct Offering
09:00 ET premarket |
Five sessions later the move was 141.2% bigger, at +60.97%. Month end +40.77% on 2024-01-31 |
| 78 | GMDA | +25.17% |
against the close of 2024-01-26
session reconstructed
Session detail |
M&A / Acquisition |
Gamida Cell Actively Pursuing Strategic Alternatives
06:00 ET premarket |
It gave back the whole move and closed 4.31% below the pre-news price. Month end +5.71% on 2024-01-31 This month ended before the fifth session after the move. |
| 79 | PRAX | +24.85% |
against the close of 2024-01-05
session reconstructed
Session detail |
Other Announcement |
Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio
08:00 ET premarket |
Five sessions later the move was 155.0% bigger, at +63.36%. Month end +73.20% on 2024-01-31 |
| 80 | CDLX | +24.61% |
against the close of 2024-01-26
session reconstructed
Session detail |
Earnings |
Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results
07:56 ET premarket |
18.3% of the move was gone five sessions later. Month end +32.41% on 2024-01-31 This month ended before the fifth session after the move. |
| 81 | BARK | +24.00% |
against the close of 2024-01-08
session reconstructed
Session detail |
Earnings |
BARK Reports Preliminary Third Quarter Fiscal Year 2024 Revenue Ahead of the ICR Conference
16:00 ET after hours |
21.5% of the move was gone five sessions later. Month end +33.04% on 2024-01-31 |
| 82 | AHT under $25M today | +23.88% |
against the close of 2024-01-30
session reconstructed
Session detail |
Other Announcement |
ASHFORD HOSPITALITY TRUST PROVIDES UPDATE ON PLAN TO PAY OFF STRATEGIC FINANCING
08:00 ET premarket |
56.2% of the move was gone five sessions later. Month end +23.88% on 2024-01-31 same session This month ended before the fifth session after the move. |
| 83 | MBTC | +23.50% |
against the close of 2024-01-29
session reconstructed
Session detail |
M&A / Acquisition |
Nocturne Acquisition Corporation Announces Postponement of Extraordinary General Meeting
08:31 ET premarket |
32.3% of the move was gone five sessions later. Month end +24.03% on 2024-01-31 This month ended before the fifth session after the move. |
| 84 | CDIO under $25M today | +22.89% |
against the close of 2023-12-29
session reconstructed
Session detail |
Other Announcement |
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
08:31 ET premarket |
29.8% of the move was gone five sessions later. Month end -12.45% on 2024-01-31 |
| 85 | RXST | +22.80% |
against the close of 2024-01-05
session reconstructed
Session detail |
Earnings |
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
10:00 ET intraday |
Five sessions later the move was 0.4% bigger, at +22.88%. Month end +23.37% on 2024-01-31 |
| 86 | ACET | +22.73% |
against the close of 2024-01-03
session reconstructed
Session detail |
Other Announcement |
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
07:00 ET premarket |
Five sessions later the move was 220.0% bigger, at +72.73%. Month end +69.89% on 2024-01-31 |
| 87 | CLNN | +22.07% |
against the close of 2024-01-05
session reconstructed
Session detail |
Other Announcement |
Clene Reports Significant Improvement in Vision and Cognition With CNM-Au8® Treatment in VISIONARY-MS Trial Long-Term Open Label Extension
07:00 ET premarket |
Five sessions later the move was 243.7% bigger, at +75.86%. Month end +70.34% on 2024-01-31 |
| 88 | ENSC under $25M today | +21.93% |
against the close of 2024-01-22
session reconstructed
Session detail |
FDA & Regulatory |
Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR
08:00 ET premarket |
Five sessions later the move was 20.0% bigger, at +26.32%. Month end +42.11% on 2024-01-31 |
| 89 | LAES More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | +21.87% |
against the close of 2024-01-09
session reconstructed
Session detail |
Guidance Change |
SEALSQ Announces FY 2023 Preliminary Unaudited Revenue of $30 Million, Marking a 29% Increase Over FY 2022
09:00 ET premarket |
Five sessions later the move was 80.0% bigger, at +39.37%. Month end +22.50% on 2024-01-31 |
| 90 | PCT | +21.67% |
against the close of 2024-01-12
session reconstructed
Session detail |
Other Announcement |
PureCycle Provides Ironton Purification Facility Production Update
08:45 ET premarket |
Five sessions later the move was 61.5% bigger, at +35.00%. Month end +63.33% on 2024-01-31 |
| 91 | RWLK | +21.57% |
against the close of 2024-01-04
session reconstructed
Session detail |
Other Announcement |
First ReWalk Personal Exoskeleton Claim Paid by Medicare
08:00 ET premarket |
72.7% of the move was gone five sessions later. Month end -2.93% on 2024-01-31 |
| 92 | LAES More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | +21.37% |
against the close of 2024-01-02
session reconstructed
Session detail |
Crypto & Treasury |
SEALSQ To Launch SEALCOIN, a digital token and advanced cryptocurrency protocol, at the Davos Space IoT and Cybersecurity Event on January 17, 2024
07:00 ET premarket |
Five sessions later the move was 212.0% bigger, at +66.67%. Month end +67.52% on 2024-01-31 |
| 93 | LAES More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | +21.29% |
against the close of 2024-01-23
session reconstructed
Session detail |
Leadership Change |
SEALSQ Announces Appointment of John O’Hara as Chief Financial Officer
16:05 ET after hours |
Five sessions later the move was 24.2% bigger, at +26.45%. Month end +26.45% on 2024-01-31 |
| 94 | BFRG under $25M today | +20.83% |
against the close of 2024-01-16
session reconstructed
Session detail |
Contract / Partnership |
BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data
07:00 ET premarket |
Five sessions later the move was 765.6% bigger, at +180.30%. Month end +84.85% on 2024-01-31 |
| 95 | BFLY | +20.79% |
against the close of 2024-01-05
session reconstructed
Session detail |
FDA & Regulatory |
Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3
08:05 ET premarket |
85.7% of the move was gone five sessions later. Month end -10.78% on 2024-01-31 |
| 96 | EHTH | +20.79% |
against the close of 2024-01-25
session reconstructed
Session detail |
Earnings |
eHealth, Inc. Announces Preliminary Results for the Fourth Quarter and Fiscal Year 2023
08:00 ET premarket |
Five sessions later the move was 45.7% bigger, at +30.29%. Month end +21.86% on 2024-01-31 This month ended before the fifth session after the move. |
| 97 | AXNX | +20.48% |
against the close of 2024-01-05
session reconstructed
Session detail |
Earnings |
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
07:00 ET premarket |
8.6% of the move was gone five sessions later. Month end +17.91% on 2024-01-31 |
| 98 | CROX | +20.33% |
against the close of 2024-01-05
session reconstructed
Session detail |
Other Announcement |
Crocs, Inc. Expects Record Annual Revenues of ~$3.95B, Up Over 11% Year-Over-Year
07:00 ET premarket |
18.8% of the move was gone five sessions later. Month end +17.38% on 2024-01-31 |
| 99 | MAIA More than one ranked move this month 2+ ranked moves | +20.33% |
against the close of 2024-01-16
session reconstructed
Session detail |
Clinical Trial Results |
MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024
09:00 ET premarket |
28.0% of the move was gone five sessions later. Month end +21.95% on 2024-01-31 |
| 100 | KIRK | +20.24% |
against the close of 2024-01-18
session reconstructed
Session detail |
Earnings |
Kirkland's Home Announces Holiday 2023 Comparable Sales Results
07:00 ET premarket |
2.0% of the move was gone five sessions later. Month end +30.95% on 2024-01-31 |
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 280 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band
4 candidate events for this board could not be anchored to a trading session and are not listed.
1 event was left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.
2 events were left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.
2 events were left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.
Company names are not shown on months older than a year, because only the current holder of each ticker is known.
Whole board, unfiltered
In January 2024, the median gainer had given back 13.1% of its move five sessions later; the largest catalyst group was Other Announcement, 39 of the 100 events, at a median of +32.5%.
Close-to-close change on the measured trading session, against the previous close.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
Which catalysts drove the board
Swipe the table sideways for the day +5 columns.
| Catalyst | Events | Share of board | Median move close to close | Median at day +5 | Still above the pre-news close at day +5 |
|---|---|---|---|---|---|
| Other Announcement | 39 | 39.0% | +32.5% | +31.3% | 87.2% of 39 |
| Earnings | 17 | 17.0% | +29.0% | +20.1% | 100.0% of 17 |
| M&A / Acquisition | 12 | 12.0% | +32.7% | +34.1% | 91.7% of 12 |
| Offering / Dilution | 7 | 7.0% | Fewer than 10 events in this group, so no figures are shown. | ||
| Contract / Partnership | 7 | 7.0% | Fewer than 10 events in this group, so no figures are shown. | ||
8 other catalyst types, 18 events: Clinical Trial Results, Leadership Change, FDA & Regulatory, Guidance Change, Uplisting / Compliance, Reverse Merger / Shell, Buyback / Dividend, Crypto & Treasury.
How much of the move survived
| Horizon | Still above the pre-news close close to close | Median change since the measured close as a share of the move |
|---|---|---|
| Day +1 | 98.0% of 100 | 0.5% given back, of 100 |
| Day +5 | 90.0% of 100 | 13.1% given back, of 100 |
| Month end | 83.2% of 95 | 2.0% given back, of 95 |
| Month end falls before day +5 for 14 of these 95 events, so this row is not a later horizon than the one above it. 95 of the 100 events have a month-end close later than the measured session; 5 have it on the measured session itself. | ||
Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.
Repeat runners
Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.
Moved twice or more inside January 2024
Two or more ranked moves this month, each on a different trading day.
| Symbol | Measured sessions | Best move |
|---|---|---|
| LAES | 3Guidance Change, Crypto & Treasury, Leadership Change | +21.87% |
| EVAX | 2Other Announcement | +113.43% |
| RUM | 2Contract / Partnership, Other Announcement | +36.21% |
| GNS | 2M&A / Acquisition, Other Announcement | +28.77% |
| SNES | 2Other Announcement, Contract / Partnership | +26.89% |
| MAIA | 2Other Announcement, Clinical Trial Results | +26.89% |
Also risen on news in earlier months
Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.
| Symbol | Months | Best move |
|---|---|---|
| PRZO | 2023-12, 2023-10 | +79.12% |
| SLDB | 2023-12, 2023-11 | +68.42% |
| PAPL | 2023-12, 2023-11 | +50.68% |
| CVM | 2023-12, 2023-10 | +41.12% |
| INBS | 2023-12, 2023-11 | +92.51% |
| VVOS | 2023-11, 2023-10 | +833.94% |
| BCDA | 2023-11, 2023-10 | +168.17% |
| CDIOthis month too | 2023-11, 2023-10 | +123.23% |
| ICCM | 2023-11, 2023-10 | +83.11% |
What the board was made of
Price before the move
Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.
When the announcement landed
Volume against normal
Industry
34 other industries, 39 events
Industry not known: 24.0%
2 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.
Against December 2023
100 events in the comparable window.
December 2023 median +42.5%, selected from the 6,174 events in that month's eligible pool
January 2024 median +31.1%, 11.4 points below December 2023. January 2024's median is taken over the 100 ranked rows, selected from the 8,863 events in that month's eligible pool.
The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.
How this ranking is measured
Close-to-close change on the measured trading session, against the previous close.
- An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
- One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
- A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
- No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.
Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.
Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.
Market cap is not shown on months older than a year, because only today's figure exists.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
This archive starts at 2020-04, the first month with ranked moves.